Introducing Leadership Changes at Rocket Doctor AI
Rocket Doctor AI Inc. is making significant strides in enhancing its leadership with the appointment of Christopher Cherry as the new Interim Chief Financial Officer. He will take the helm from David Worner, effective December 8. As a key member of the company, Mr. Cherry has been serving as the Chair of the Audit Committee and brings with him a wealth of experience.
Gratitude for Previous Leadership
The team at Rocket Doctor AI expresses sincere gratitude to David Worner for his dedicated service to the company. His contributions have been instrumental in driving the organization forward, and the company wishes him all the best in his future endeavors.
Stock Options and Restricted Share Units Granted
In addition to this leadership transition, Rocket Doctor AI has also announced a major grant of stock options and restricted share units. The company is issuing a total of 579,028 stock options that can be exercised at a price of $0.84 per share. These options are set to remain valid for a period of three to five years. Simultaneously, they are awarding 931,112 restricted share units, which are applicable for a term ranging between two to five years. This initiative aims to align the interests of management and team members with the company's performance.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. is pioneering in delivering AI-powered healthcare solutions that have been meticulously developed by physicians to ensure quality care is accessible for all patients. Central to their innovative technology is the Global Library of Medicine (GLM), a decision support system that has been validated by clinicians worldwide.
Revolutionizing Access to Healthcare
Rocket Doctor Inc. operates an AI-driven digital health platform and marketplace, which empowers healthcare providers. The company has successfully supported over 300 medical professionals, facilitating care for more than 700,000 patient visits. Their technology enables doctors to efficiently establish and manage virtual or hybrid in-person practices, improving patient access and healthcare efficiency.
Enhancing the Physician-Patient Relationship
The solutions offered by Rocket Doctor AI significantly reduce administrative burdens for physicians while ensuring consistent care. This focus creates additional time for meaningful interactions between doctors and patients, enhancing the overall healthcare experience.
Commitment to Underserved Communities
Rocket Doctor AI's mission is to extend its services especially to underserved, rural, and remote communities in Canada. By leveraging advanced AI, large language models, and interconnected medical devices, the company aims to redefine healthcare accessibility, making it more equitable and patient-centered.
Contact Information
If you would like to learn more about the groundbreaking products and services from Rocket Doctor AI Inc., feel free to reach out: Email: info@rocketdoctor.ai or visit www.rocketdoctor.ai.
For further inquiries, contact:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io
Frequently Asked Questions
1. Who is the new Interim CFO of Rocket Doctor AI?
Christopher Cherry has been appointed as the Interim Chief Financial Officer.
2. What stock options has Rocket Doctor AI granted?
The company has granted 579,028 stock options exercisable at $0.84 per share.
3. How are the restricted share units structured?
931,112 restricted share units have been granted, valid for periods between two and five years.
4. What technology does Rocket Doctor AI leverage?
They utilize AI-powered solutions and the Global Library of Medicine for enhanced healthcare delivery.
5. How does Rocket Doctor AI support underserved communities?
The company focuses on improving healthcare access in rural and remote regions, ensuring equality in healthcare delivery.